U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H27NO5.ClH
Molecular Weight 397.893
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CHROMONAR HYDROCHLORIDE

SMILES

Cl.CCOC(=O)COC1=CC2=C(C=C1)C(C)=C(CCN(CC)CC)C(=O)O2

InChI

InChIKey=KSQIAZKOUOEHSA-UHFFFAOYSA-N
InChI=1S/C20H27NO5.ClH/c1-5-21(6-2)11-10-17-14(4)16-9-8-15(12-18(16)26-20(17)23)25-13-19(22)24-7-3;/h8-9,12H,5-7,10-11,13H2,1-4H3;1H

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C20H27NO5
Molecular Weight 361.4321
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including http://adisinsight.springer.com/drugs/800000219

Chromonar is a coronary vasodilator agent, it dilates coronary vessels and increases coronary blood flow volume rate, contributes to the development of collateral circulation (with prolonged use), improves metabolic processes in myocardium. The mechanism of action of a role played by its inhibitory effect on phosphodiesterase, accompanied by accumulation in the cells of cyclic 3 ', 5'-adenosine monophosphate. Due to the relatively low therapeutic efficacy Chromonar use is limited, mainly in the early stages of coronary heart disease with angina pectoris in the absence of long-standing and long strokes, when there is no expressed stenotic process.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Intensain

Approved Use

Indications for use: Angina without expressed stenotic process protracted and prolonged attacks, postinfarction period.
PubMed

PubMed

TitleDatePubMed
Cardioprotective effects of carbocromen in awake and anesthetized dogs with amitriptyline poisoning.
1985 Jul-Aug
Cloricromene, a semi-synthetic coumarin derivative, inhibits tumor necrosis factor-alpha production at a pre-transcriptional level.
2001 Apr 27
Effect of estrogen replacement therapy on distribution of myocardial blood flow in female anesthetized rabbits.
2001 Sep
Simultaneous determination of cloricromene and its active metabolite in rabbit aqueous humor by high-performance liquid chromatography.
2002 Feb 5
In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form.
2004 Jun 18
Cloricromene, a coumarine derivative, reduced the development of periodontitis in rats.
2006 Apr
Retinal and systemic pharmacokinetics of the anti-inflammatory drug cloricromene following oral administration in the rat and rabbit.
2007 Jun
Patents

Sample Use Guides

Inside after food: 0,075 - 0,15 g (1 - 2 tablets) 3 times a day. In more severe cases, to begin receiving 0.15 g 4 times a day, and after improving the dose is reduced to 0.075 g of 3 - 4 times daily. It is noted that the effect of the drug increases (to 10 - 30th day) and lasts a long time. Take in a few weeks or months (up to 6 months).
Route of Administration: Oral
In Vitro Use Guide
In bovine heart mitochondria ho/h-1 ratios in repeated scans increased in presence of carbocromen (20--40 umol/l)
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:13:46 UTC 2023
Edited
by admin
on Fri Dec 15 15:13:46 UTC 2023
Record UNII
52C937V399
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CHROMONAR HYDROCHLORIDE
MI   USAN  
USAN  
Official Name English
NSC-110430
Code English
CHROMONAR HYDROCHLORIDE [USAN]
Common Name English
[[3-[2-(Diethylamino)ethyl]-4-methyl-2-oxo-2H-1-benzopyran-7-yl]oxy]acetic acid ethyl ester hydrochloride
Systematic Name English
CARBOCROMEN HYDROCHLORIDE [JAN]
Common Name English
A-27053
Code English
CARBOCROMEN HYDROCHLORIDE
JAN   MART.   WHO-DD  
Common Name English
Carbocromen hydrochloride [WHO-DD]
Common Name English
CHROMONAR HCL
Common Name English
AG-3
Code English
ACETIC ACID, ((3-(2-(DIETHYLAMINO)ETHYL)-4-METHYL-2-OXO-2H-1-BENZOPYRAN-7-YL)OXY)-, ETHYL ESTER, HYDROCHLORIDE
Common Name English
CARBOCROMEN HYDROCHLORIDE [MART.]
Common Name English
CHROMONAR HYDROCHLORIDE [MI]
Common Name English
Code System Code Type Description
NCI_THESAURUS
C166807
Created by admin on Fri Dec 15 15:13:46 UTC 2023 , Edited by admin on Fri Dec 15 15:13:46 UTC 2023
PRIMARY
RXCUI
81980
Created by admin on Fri Dec 15 15:13:46 UTC 2023 , Edited by admin on Fri Dec 15 15:13:46 UTC 2023
PRIMARY RxNorm
PUBCHEM
12603
Created by admin on Fri Dec 15 15:13:46 UTC 2023 , Edited by admin on Fri Dec 15 15:13:46 UTC 2023
PRIMARY
FDA UNII
52C937V399
Created by admin on Fri Dec 15 15:13:46 UTC 2023 , Edited by admin on Fri Dec 15 15:13:46 UTC 2023
PRIMARY
SMS_ID
100000084871
Created by admin on Fri Dec 15 15:13:46 UTC 2023 , Edited by admin on Fri Dec 15 15:13:46 UTC 2023
PRIMARY
EPA CompTox
DTXSID2048749
Created by admin on Fri Dec 15 15:13:46 UTC 2023 , Edited by admin on Fri Dec 15 15:13:46 UTC 2023
PRIMARY
ChEMBL
CHEMBL163672
Created by admin on Fri Dec 15 15:13:46 UTC 2023 , Edited by admin on Fri Dec 15 15:13:46 UTC 2023
PRIMARY
ECHA (EC/EINECS)
211-511-5
Created by admin on Fri Dec 15 15:13:46 UTC 2023 , Edited by admin on Fri Dec 15 15:13:46 UTC 2023
PRIMARY
EVMPD
SUB01048MIG
Created by admin on Fri Dec 15 15:13:46 UTC 2023 , Edited by admin on Fri Dec 15 15:13:46 UTC 2023
PRIMARY
MERCK INDEX
m3513
Created by admin on Fri Dec 15 15:13:46 UTC 2023 , Edited by admin on Fri Dec 15 15:13:46 UTC 2023
PRIMARY Merck Index
CAS
655-35-6
Created by admin on Fri Dec 15 15:13:46 UTC 2023 , Edited by admin on Fri Dec 15 15:13:46 UTC 2023
PRIMARY
NSC
110430
Created by admin on Fri Dec 15 15:13:46 UTC 2023 , Edited by admin on Fri Dec 15 15:13:46 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE